4.5 Article

Brain connectivity and novel network measures for Alzheimer's disease classification

Journal

NEUROBIOLOGY OF AGING
Volume 36, Issue -, Pages S121-S131

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.04.037

Keywords

SVM; Classification; Sensitivity; Specificity; Maximum flow; Connectivity matrix; Alzheimer's disease; Network measures; Graph; Ranking

Funding

  1. National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01 EB008281, R01 EB008432, R21 EB01651]
  2. National Institute on Aging (NIA) [P50 AG016570-019002, R01 AG040060, U01 AG024904-01]
  3. NIBIB
  4. National Institute of Mental Health
  5. US National Library of Medicine [R01 LM05639]
  6. National Center for Research Resources [AG016570, AG040060, EB01651, MH097268, LM05639, RR019771]
  7. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health [NIH]) [U01 AG024904]
  8. NIA
  9. Abbott
  10. Alzheimer's Association
  11. Alzheimer's Drug Discovery Foundation
  12. Amorfix Life Sciences Ltd
  13. AstraZeneca
  14. Bayer HealthCare
  15. BioClinica Inc
  16. Biogen Idec Inc
  17. Bristol-Myers Squibb Company
  18. Eisai Inc
  19. Elan Pharmaceuticals Inc
  20. Eli Lilly and Company
  21. F. Hoffmann-La Roche Ltd
  22. GE Healthcare
  23. Innogenetics, N.V.
  24. IXICO Ltd
  25. Janssen Alzheimer Immunotherapy Research & Development, LLC
  26. Johnson & Johnson Pharmaceutical Research & Development LLC
  27. Medpace Inc
  28. Merck Co Inc
  29. Meso Scale Diagnostics LLC
  30. Novartis Pharmaceuticals Corporation
  31. Pfizer Inc
  32. Servier
  33. Synarc Inc
  34. Takeda Pharmaceutical Company
  35. Canadian Institutes of Health Research
  36. NIH grants from the National Institute of General Medical Sciences [P30 AG010129, K01 AG030514]
  37. NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR019771] Funding Source: NIH RePORTER
  38. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008281, U54EB020403, P41EB015922, R01EB008432] Funding Source: NIH RePORTER
  39. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097268] Funding Source: NIH RePORTER
  40. NATIONAL INSTITUTE ON AGING [P50AG005142, K01AG030514, RF1AG041915, R01AG040060, P50AG016570, P30AG010129, U01AG024904] Funding Source: NIH RePORTER
  41. NATIONAL LIBRARY OF MEDICINE [R01LM005639] Funding Source: NIH RePORTER

Ask authors/readers for more resources

We compare a variety of different anatomic connectivity measures, including several novel ones, that may help in distinguishing Alzheimer's disease (AD) patients from controls. We studied diffusion-weighted magnetic resonance imaging from 200 subjects scanned as part of the Alzheimer's Disease Neuroimaging Initiative. We first evaluated measures derived from connectivity matrices based on whole-brain tractography; next, we studied additional network measures based on a novel flow-based measure of brain connectivity, computed on a dense 3-dimensional lattice. Based on these 2 kinds of connectivity matrices, we computed a variety of network measures. We evaluated the measures' ability to discriminate disease with a repeated, stratified 10-fold cross-validated classifier, using support vector machines, a supervised learning algorithm. We tested the relative importance of different combinations of features based on the accuracy, sensitivity, specificity, and feature ranking of the classification of 200 people into normal healthy controls and people with early or late mild cognitive impairment or AD. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available